CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers? early trial of CBX-250 begins
Disease control Recruiting nowThis early-stage study tests a new drug, CBX-250, in people with certain types of blood cancers (myeloid leukemias) that have returned or not responded to standard treatments. The main goals are to find a safe dose and see how well people tolerate the drug. About 72 participants …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:50 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) who have run out of standard treatments. The main goals are to find a safe dose and check for side effects. About 105 participant…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
New transplant combo targets tough leukemia
Disease control Recruiting nowThis study tests a stronger chemotherapy combination (thiotepa, busulfan, fludarabine) before a stem cell transplant for people with an aggressive form of chronic myelomonocytic leukemia (CMML). The goal is to see if this approach helps patients live longer without the cancer com…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE4 • Sponsor: Sun Yuqian • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
New combo therapy aims to control rare blood cancers
Disease control Recruiting nowThis study tests a new drug called axatilimab, alone and with the standard drug ruxolitinib, in people with myelofibrosis or chronic myelomonocytic leukemia. The goal is to find a safe dose and see if the combination helps control the disease. About 66 adults who have not respond…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New drug cocktails aim to tame deadly transplant complication
Disease control Recruiting nowThis study is for people with blood cancers who need a stem cell transplant from an unrelated donor with a different blood type. The goal is to find which drug combination works best to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 08:29 UTC